SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.86 Cr | ₹0.55 Cr | ₹0.55 Cr | ₹0.55 Cr | ₹2.74 Cr |
What is the latest Contingent Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.86 Cr |
| Mar2024 | ₹0.55 Cr |
| Mar2023 | ₹0.55 Cr |
| Mar2022 | ₹0.55 Cr |
| Mar2017 | ₹2.74 Cr |
How is Contingent Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.86 Cr | 56.18 | |
| Mar2024 | ₹0.55 Cr | 0.00 | |
| Mar2023 | ₹0.55 Cr | 0.00 | |
| Mar2022 | ₹0.55 Cr | -79.96 | |
| Mar2017 | ₹2.74 Cr | - | |
Compare Contingent Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,396.8 Cr | -3.9% | -7.5% | -31.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,753.0 Cr | -0.2% | 6.1% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,998.0 Cr | -1.4% | -4.9% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,186.0 Cr | 0.8% | 5% | 12.9% | Stock Analytics | |
| CIPLA | ₹120,960.0 Cr | -1.3% | -0.5% | 1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,759.0 Cr | -0.7% | 5.1% | 4.9% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -3.9% |
-7.5% |
-31.4% |
| SENSEX | -0.6% |
2.2% |
5.3% |
You may also like the below Video Courses